Cegedim S.A (CGM) | Stock Overview & Key Data
Cegedim S.A. | Small-cap | Healthcare
Cegedim S.A. | Small-cap | Healthcare
Cegedim S.A Performance Comparison
Stock Range
Today's Range
Low: €10.40
High: €10.50
on July 18, 2025
52 Week Range
Low: €10.30
High: €13.80
on April 7, 2025
on December 18, 2024
All-Time High: €44.50 on January 29, 2018
Explore how other French stocks compare to their 52-week ranges: View FR Market 52-Week Insights
Key Statistics
Market Cap
€145.9M
EPS
-1.10
P/E Ratio (TTM)
92.86
Forward P/E
6.97
P/B Ratio
0.55
PEG Ratio
6.97
Div. Yield
N/A
ROE
-4.95%
Beta
1.033
Debt to Equity
115.34
Financial Highlights
Profitability
Gross Margin
62.17%
Operating Margin
8.56%
Profit Margin
-2.25%
Returns and Earnings
Return on Assets (TTM)
2.46%
Return on Equity (TTM)
-4.95%
EBITDA
€92.9M
Net Income (TTM)
€-14.7M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
€47.73
Quarterly Revenue Growth (YoY)
6.50%
Quarterly Earnings Growth (YoY)
105.57%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Cegedim S.A CGM | 145.93M Small-cap | -2.80% | -1.42% | -7.96% | -12.97% | -21.51% | -20.31% | -50.48% | -68.00% |
| Equasens EQS | 757.57M Mid-cap | 3.32% | 9.01% | 44.99% | 37.25% | 14.48% | 4.90% | -37.24% | -37.32% |
| Abl Diagnostics ABLD | 86.82M Small-cap | 0.00% | 0.00% | -0.91% | 82.89% | 121.54% | 94.64% | -91.42% | 20.31% |
| Smaio S.A ALSMA | 36.90M Small-cap | 12.93% | 51.62% | 56.70% | 139.93% | 164.11% | 53.40% | 79.95% | 21.97% |
| Intrasense S.A ALINS | 15.22M Small-cap | 0.00% | -9.68% | -3.45% | 12.00% | 12.00% | -6.67% | -15.15% | -66.67% |
| Ama Corp Plc ALAMA | 14.39M Small-cap | 8.00% | 8.00% | 35.00% | 58.82% | 58.82% | 12.50% | -74.53% | -95.91% |
Ownership & Short Interest
Insider Ownership
57.12%
Institutional Ownership
16.75%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
11K
Average 90-Day Volume
10K
Cegedim S.A Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Cegedim S.A would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is CGM's 52-week high and low?
- In the last 52 weeks, Cegedim S.A reached a high of €13.80 (on December 18, 2024) and a low of €10.30 (on April 7, 2025).
- What is the market cap and P/E ratio for CGM?
- Curious about Cegedim S.A's size and valuation? Its market capitalization stands at 145.93M. When it comes to valuation, the P/E ratio (trailing twelve months) is 92.86, and the forward P/E (looking ahead) is 6.97.
- Does CGM pay dividends? If so, what's the yield?
- As for dividends, Cegedim S.A isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Cegedim S.A's main competitors or similar companies to consider before investing?
When looking at Cegedim S.A, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Equasens
EQS757.57M Healthcare Health Information Services 4.90% -37.24% Abl Diagnostics
ABLD86.82M Healthcare Health Information Services 94.64% -91.42% Smaio S.A
ALSMA36.90M Healthcare Health Information Services 53.40% 79.95% Intrasense S.A
ALINS15.22M Healthcare Health Information Services -6.67% -15.15% Ama Corp Plc
ALAMA14.39M Healthcare Health Information Services 12.50% -74.53% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Cegedim S.A.? (e.g., ROE, Debt/Equity)
- To get a sense of Cegedim S.A's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -4.95%, the Debt to Equity ratio from the most recent quarter is 115.34, and its Gross Profit Margin stands at 62.17%.
- What is the recent revenue and earnings growth for CGM?
- Looking at Cegedim S.A's growth, its revenue over the trailing twelve months (TTM) was €654M. Compared to the same quarter last year (YoY), quarterly revenue grew by 6.50%, and quarterly earnings saw a YoY growth of 105.57%.
- How much of CGM stock is held by insiders and institutions?
- Wondering who owns Cegedim S.A stock? Company insiders (like executives and directors) hold about 57.12% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 16.75%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.